Defunct Company
Total Trials
12
As Lead Sponsor
9
As Collaborator
3
Total Enrollment
295
NCT00477321
Safety Study of IL-7 in HIV-infected Patients (Inspire)
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2007
Completion: Jul 31, 2010
NCT00492440
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
Completion: Dec 31, 2010
NCT01025596
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)
Phase: Phase 1/2
Completion: Mar 31, 2012
Role: Collaborator
NCT00684008
Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant
Start: Mar 31, 2008
Completion: Apr 30, 2011
NCT01025297
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone
Start: Jul 31, 2008
Completion: Mar 31, 2013
NCT01024894
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy
Start: Jan 31, 2009
Completion: Dec 31, 2012
NCT01027065
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Start: Dec 31, 2009
NCT01190111
Study on Interleukin-7 (CYT107) in HIV Patients
Phase: Phase 2
Start: Jan 31, 2010
Completion: Jun 30, 2013
NCT01241643
Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
Start: Sep 30, 2010
NCT01019551
Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients
Completion: Feb 28, 2013
NCT01368107
Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
Start: Jun 30, 2011
Completion: Jun 30, 2014